ethoxyidazoxan has been researched along with talipexole in 1 studies
| Studies (ethoxyidazoxan) | Trials (ethoxyidazoxan) | Recent Studies (post-2010) (ethoxyidazoxan) | Studies (talipexole) | Trials (talipexole) | Recent Studies (post-2010) (talipexole) |
|---|---|---|---|---|---|
| 14 | 2 | 0 | 426 | 2 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colpaert, FC; Pauwels, PJ | 1 |
1 other study(ies) available for ethoxyidazoxan and talipexole
| Article | Year |
|---|---|
Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Azepines; Brimonidine Tartrate; Calcium; CHO Cells; Clonidine; Cricetinae; DNA, Recombinant; Dose-Response Relationship, Drug; Drug Interactions; Epinephrine; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Idazoxan; Kinetics; Medetomidine; Mice; Oxymetazoline; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Transfection | 2000 |